Topical Anesthesia for Closed PKP vs Retrobulbar Anesthesia for Open-sky PKP

Sponsor
Wenzhou Medical University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02826174
Collaborator
(none)
60
1
4
12
5

Study Details

Study Description

Brief Summary

Penetrating keratoplasty (PKP) is an open-sky surgery that fundamentally has not changed for more than 100 years. Because conventional PKP is associated with the potential for the development of devastating complications such as expulsive suprachoroidal hemorrhage and endophthalmitis, we modified the technique to one that is a closed surgery under topical anesthesia with the anterior chamber maintained to achieve favorable results. Topical anesthesia is an attractive alternative to traditional injection local anesthesia since the potentially serious complications associated with retrobulbar and peribulbar anesthesia can be avoided. The closed PKP procedure with the stable anterior chamber essentially changes the open nature of conventional PKP. The advantages, i.e., decreased surgical risks, postoperative complications, and surgical difficulties, make PKP viable in most complicated cases.

Condition or Disease Intervention/Treatment Phase
  • Procedure: closed PKP under topical anesthesia
  • Procedure: open-sky PKP under retrobulbar anesthesia
  • Drug: Anti-Rejection Agents
  • Drug: Anti-Inflammatory Agents
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Study Start Date :
Dec 1, 2015
Anticipated Primary Completion Date :
Dec 1, 2016
Anticipated Study Completion Date :
Dec 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: closed PKP under topical anesthesia

a closed corneal transplantation under topical anesthesia with the anterior chamber maintained

Procedure: closed PKP under topical anesthesia
a closed corneal transplantation under topical anesthesia with the anterior chamber maintained

Drug: Anti-Rejection Agents
Anti-Rejection Agents for both groups

Drug: Anti-Inflammatory Agents
Anti-Inflammatory Agents for both groups

Active Comparator: open-sky PKP under retrobulbar anesthesia

an open-sky corneal transplantation under retrobulbar anesthesia

Procedure: open-sky PKP under retrobulbar anesthesia
an open-sky corneal transplantation under retrobulbar anesthesia

Drug: Anti-Rejection Agents
Anti-Rejection Agents for both groups

Drug: Anti-Inflammatory Agents
Anti-Inflammatory Agents for both groups

Other: Anti-Rejection Agents

Anti-Rejection Agents for both groups

Procedure: closed PKP under topical anesthesia
a closed corneal transplantation under topical anesthesia with the anterior chamber maintained

Procedure: open-sky PKP under retrobulbar anesthesia
an open-sky corneal transplantation under retrobulbar anesthesia

Other: Anti-Inflammatory Agents

Anti-Inflammatory Agents for both groups

Procedure: closed PKP under topical anesthesia
a closed corneal transplantation under topical anesthesia with the anterior chamber maintained

Procedure: open-sky PKP under retrobulbar anesthesia
an open-sky corneal transplantation under retrobulbar anesthesia

Outcome Measures

Primary Outcome Measures

  1. best corrected visual acuity [preoperative]

  2. best corrected visual acuity [1 week after PKP]

  3. best corrected visual acuity [2 weeks after PKP]

  4. best corrected visual acuity [1 month after PKP]

  5. best corrected visual acuity [3 months after PKP]

  6. best corrected visual acuity [6 months after PKP]

Secondary Outcome Measures

  1. Endothelial cell density [1 week after PKP]

  2. Endothelial cell density [2 weeks after PKP]

  3. Endothelial cell density [1 month after PKP]

  4. Endothelial cell density [3 months after PKP]

  5. Endothelial cell density [6 months after PKP]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • active bacterial keratitis, for which ulceration progressed despite maximum antibacterial medication;

  • refractory fungal keratitis that did not respond to antifungal agents;

  • nonactive HSK, for which corneal opacities with or without new vessels involved the optical zone;

  • ocular acid burn and thermal burn with partial limbal deficiency (50% or less) that, after more than half a year of preoperative treatment, showed reepithelialization and less than 2 quadrants limbal neovascularization.

Exclusion Criteria:
  • Patients with keratolimbal allograft transplantation, total limbal stem cell deficiency secondary to ocular burns, and other ocular diseases (ie, amblyopia, age-related cataract, glaucoma, macular edema, and mac ular degeneration) were excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Eye Hospital, Wenzhou Medical College Wenzhou Zhejiang China 325027

Sponsors and Collaborators

  • Wenzhou Medical University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jinyang Li, PhD, Wenzhou Medical University
ClinicalTrials.gov Identifier:
NCT02826174
Other Study ID Numbers:
  • Closed PKP
First Posted:
Jul 7, 2016
Last Update Posted:
Jul 7, 2016
Last Verified:
Jul 1, 2016

Study Results

No Results Posted as of Jul 7, 2016